Endocrinology

Top Story

Biologics application submitted for osteoporosis drug

July 23, 2016

A Biologics License Application for romosozumab, an investigational monoclonal antibody much anticipated as a therapy for the treatment of osteoporosis in postmenopausal women at high risk for fracture, has been submitted to the FDA by co-developers Amgen and UCB, according to a press release from Amgen.

Romosozumab inhibits the protein sclerostin to increase bone formation and decrease bone resorption.

In the Journals

Female physicians make 'substantially' less than male counterparts

July 22, 2016
Significant salary differences exist between male and female physicians at public medical schools, according to findings published in JAMA Internal Medicine. This gap…

Top 5 online stories posted in the last month

July 22, 2016
Endocrine Today compiled a list of the top five news reports posted from June 21 to July 21. Healio.com/Endocrinology readers were interested in a new name proposed for…
In the Journals

Individuals with mood disorders, low cortisol may have higher risk for obesity, other metabolic disorders

July 22, 2016
Recent findings indicated associations between low cortisol levels, metabolic disorders and cardiovascular risk factors among individuals with mood disorders…

Nearly half of physicians see fewer patients each day due to EHR use

July 22, 2016
Physicians have mixed feelings about electronic health record usage, according to a report published by Physicians Practice. The 2016 Tech Report included an annual…
More News Headlines »
CME Video

Navigating a New Era of Personalized Type 2 Diabetes Care: Taking the Road Less Traveled

This activity is supported by an independent educational grant from Boehringer-Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC.

In the United States, over 29 million people have diabetes, of which approximately 95% of cases are type 2 diabetes…
More »
Video
Meeting News Coverage

VIDEO: GLP-1 receptor agonists demonstrate increased efficacy with insulin in combination therapies

July 5, 2016
More »
Featured
Highlights from ADA

Highlights from ADA

CME CNE CPE

The Emerging Biosimilar Therapeutic Landscape: Scientific Foundations and Clinical Implications

This activity is supported by an educational grant from Boehringer-Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC.

Recent processes have been established to facilitate the production, validation, and utilization of biosimilars…
More »
Current Issues
View the Current Issues
morganatic-roan